We present a novel single‐platform assay for determination of the absolute number of
human blood monocyte subpopulations, ie, the CD14 ++ CD16 − and the CD14 + CD16 ++ …

EvA (Emphysema versus Airway disease) is a multicentre project to study mechanisms and
identify biomarkers of emphysema and airway disease in chronic obstructive pulmonary …

Small sputum macrophages represent highly active cells that Increase In the airways of
patients with Inflammatory diseases such as chronic obstructive pulmonary disease (COPD). It …

Background The development of several disorders, such as cardiovascular diseases, diabetes
and osteoporosis, has been linked to suboptimal dietary magnesium (Mg) intake. In this …

Endotoxin (Lipopolysaccharide, LPS) is a potent inducer of inflammation and there is various
LPS contamination in the environment, being a trigger of lung diseases and exacerbation. …

While 25-OH-D3 serum levels in humans undergo a large seasonal variation, 1,25-(OH)2-D3
is regulated within a narrow range. We speculate that in addition to the known genomic …

We studied HLA class II molecules on blood monocyte subsets, blood dendritic cells, sputum
macrophages, and monocyte-derived macrophages at the protein (flow cytometry) and …

The CD16-positive monocytes have been first described in 1988 but to date no selective
defect in the number of these cells in blood has been reported. We now describe a family in …

The EvA study is a European Union-funded project under the Seventh Framework Programme
(FP7), which aims at defining new markers for chronic obstructive pulmonary disease (…

Background: Exhaled breath condensate (EBC) allows noninvasive monitoring of inflammation
in the lung. Activation of inflammatory cells results in an increased production of reactive …